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Abstract  
 Background: Carbohydrate-rich fluids are used to improve postoperative 
recovery but the effectiveness of the product for reducing length of hospital 
stay is uncertain. 
 Objective: To assess the effectiveness of preoperative loading with 
carbohydrates on postoperative outcomes. 
 Participants: Forty six patients booked for elective colorectal surgery.  
 Methods: Participants were allocated to a Carbohydrate-rich fluid group or 
Usual Care group during their pre-admission clinic visit. The primary outcome 
was ‘Time to readiness for discharge’.  
 Results: Patients in the  control group spent on average 4.3 days (95% 
confidence interval 3.2 to 5.7) and the Carbohydrate-rich fluid group spent 4.1 
days (95% confidence interval 3.2 to 5.4)  until the primary outcome was met 
(p=0.824).  
 Conclusion: The safety of preoperative high carbohydrate fluids is supported 
but we were unable to confirm or refute the benefit of CHO for shorter 
hospital stay following elective colorectal surgery.  
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Introduction 
Surgical fast track pathways, based on work by Kehlet et al (2002), employ a number 
of perioperative strategies, which aim to improve postoperative outcomes
1
. One of the 
components of these pathways is the use of preoperative, oral, carbohydrate-rich 
nutritional supplement (CHO). These supplements have been shown to counteract 
postoperative insulin resistance and stress reactions associated with surgical trauma
2
 
and to improve postoperative recovery
3
. Preoperative oral CHO appears to be 
effective in reducing thirst, hunger and fatigue in the postoperative period
4
 and in 
reducing anxiety preoperatively
5
. The effect of CHO on postoperative nausea and 
vomiting is less clear. One study showed that drinking 800ml of a carbohydrate fluid 
on the night before surgery and 400mls 2 hrs prior to surgery reduced nausea and 
vomiting in the carbohydrate group following laparoscopic cholecystectomy
6
. 
However, a study in a similar population and using the same pre-operative regimen, 
found no differences between groups on any of the measured outcomes, including 
nausea and vomiting
7
. Nor did the product reduce nausea and vomiting in patients 
who received the drink before coronary artery surgery
8
 or thyroidectomy
9
. 
Although some advantages of using a carbohydrate-rich preoperative beverage have 
been demonstrated, there is less information about whether these advantages translate 
into improved post-operative clinical outcomes, such as shorter recovery times. For 
example, clinicians and hospital administrators are interested in whether pre-loading 
with a carbohydrate drink reduces hospital length of stay. Following abdominal 
surgery, patients usually remain in hospital until their gastrointestinal function has 
been restored, so any treatment which facilitates this function may be useful.  
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However, in their original paper, Kehlet and colleagues (2002) suggested that the 
evidence base for the use of carbohydrate enriched pre-operative drinks to improve 
outcomes required further investigation before the intervention could be 
recommended
1
. Since that time, there have been three trials of CHO that have 
included gastroenterology patients but their findings are contradictory
10-12
. None of 
these trials compared ‘usual care’ with the administration of a pre-operative 
carbohydrate drink, and one included a heterogeneous population
11
, which may have 
masked any effects the product may have in a more homogeneous group.  
At the Royal Brisbane and Women’s Hospital, a standard protocol exists for fasting 
pre-operative patients, which could be easily adapted to include a clear carbohydrate 
drink for some patients. This provided an opportunity for an independent, pragmatic 
trial to add to the evidence around the use of preoperative CHO. Consequently, the 
primary aim of this study was to test if a pre-operative carbohydrate drink would 
improve clinical outcomes among gastroenterology patients undergoing elective 
bowel surgery.  
 
Methods: 
Design:  
We used a single-site, parallel-group, randomized controlled trial. The Consolidated 
Standards of Reporting Trials (CONSORT 2010) Statement, a method for ensuring 
transparent reporting of trials (Figure 1), was used to guide trial design and 
reporting
13
.  
Participants and setting:  
The trial was conducted at the Royal Brisbane and Women's Hospital, Brisbane, 
Australia (RBWH). All colorectal patients undergoing elective bowel surgery and 
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who were > 18 years of age were eligible for inclusion. Exclusion criteria included 
those who were non-English speaking and who did not have an interpreter; pregnant 
women; those unable to consume clear fluids; those with gastrointestinal obstruction, 
liver cirrhosis, diabetes mellitus or cognitive impairment; and those who were 
receiving corticosteroid treatment exceeding 5 mg/day. We also excluded, participants 
enrolled in other trials. 
The trial was approved by the Hospital’s Human Research Ethics Committee and was 
pre-registered (ACTRN12611000868987). All participants provided written consent. 
Intervention 
Patients randomized to the intervention arm of the study were asked to drink 800ml of 
the CHO between 1900 and 2400 hours on the night before surgery and to have no 
solid food from midnight. The beverage is a clear fluid with 50 kcal per 100 ml, 290 
mOsm/kg, and a pH of 5.0). In accordance with the RBWH protocol, other clear 
fluids were allowed during the night. At 0500 hours on the morning of surgery, 
patients were asked to drink a further 200mls of the solution and to record any side-
effects caused by the drink.  
Control 
Patients randomized to the control arm of the study followed the RBWH protocol, that 
is, they were not permitted to take solid food from midnight but could drink clear 
fluids up to 0500 hours. Patients in both groups were asked to keep a record of their 
fluid intake pre-operatively. Details were recorded on a pre-prepared form, which 
sought information about both the quantity and type of fluids consumed.  
Randomisation 
We used a computer generated randomized list to determine allocation sequence and a 
telephone service was used to allocate patients to their group. Randomisation was in a 
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1:1 ratio between the two study groups. Block randomisation was used with random 
variation in block sizes. In trials with relatively small numbers, this process ensures 
that an equal number of participants are allocated to each group and that the allocation 
to the group is not predictable. The process reduces the potential for allocation bias, or 
the opportunity to select particular patients for a one group or the other.  
Procedure 
Patients were screened, consented and enrolled at the pre admission clinic and then 
randomized to either the routine care group (Control) or the CHO group 
(Intervention). Baseline demographic and risk factor data were also collected at this 
stage. Surgery-related data was retrieved from the operating theatre database and 
outcome data recorded prospectively on a pre-prepared outcome data sheet. Patients 
were followed until hospital discharge or death and any reason for a delay in 
discharge noted. 
 
Post operatively, care was individualised according to the type of surgery but most 
patients followed the standard protocol. That is, clear fluids from day one followed by 
free fluids, such as milk based drinks, pureed soups etc. on day 2-4 and to a general 
diet when tolerated. Some patients, with uneventful surgery, were placed on a rapid 
rehabilitation diet, which involved clear fluids and, if tolerated free fluids at the next 
meal, followed by a general diet if free fluids were tolerated. No record was kept of 
which patients received which approach. All patients go through bed exercises, 
supervised by a physiotherapist, on the day after surgery and are mobilised on day 
two if their pain is well managed. 
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Surgeons were unaware of group allocation but the trial was not blinded to patients or 
clinical staff. None of the investigators had any conflicts of interest and were not 
involved with sponsorship from the product manufacturers. The high carbohydrate 
beverage was not donated. The primary outcome was readiness for discharge. This 
was assigned by ward staff (not research staff or investigators) and there was no 
indication in the medical record to indicate to which arm of the study the patient was 
assigned. Consequently, the outcome was blinded to investigators.  
 
Outcome Measures 
Primary Outcome 
1. Time to readiness for discharge: Time in days (or hours) until all of the 
following criteria were met: passing flatus, stool and urine; eating 
satisfactorily (75% diet according to the patients ‘Food and Fluid 
Consumption Chart’); managing on oral analgesics; afebrile; mobilising 
independently to shower and toilet; requiring wound dressing changes less that 
twice daily; without drains requiring inpatient management.  
 
Secondary Outcomes 
1. Time to first flatus 
2. Time to first bowel movement 
3. Mortality: death from any cause whilst on the trial 
4. Adverse outcomes (such as re-admission, aspiration, any reaction or side 
effects caused by the drink).  
Sample Size and study power 
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The primary endpoint in this study was time to readiness for discharge. We based our 
sample size calculation on the results of a small study
10
 that showed a mean  reduction 
of 2.5 days in patients having colorectal surgery. To show such a difference with 80% 
power at p=0.05 we required 27 participants in each arm. We intended to inflate this 
by an additional three patients per arm (60 patients in all) to allow for any drop outs 
or missing data. We did not have any useful data on which to base a sample size 
calculation for secondary outcomes. 
Statistical methods  
All patients for whom outcome data were available were analysed in their allocated 
treatment groups (i.e. intention to treat).  To reduce the effect of outliers and skewness 
within the data, continuous outcome variables were logarithmically transformed and 
analysed using t-tests. Geometric means and 95% confidence intervals were reported.  
Categorical outcome measures were analysed with chi-squared; Fisher’s exact test 
was used when expected cell counts became small. All study outcomes were analysed 
using a two-sided P-value of less than .05 to indicate statistical significance. Data was 
analysed using IBM SPSS Statistics 19. (IBM Corporation, 2010) 
Results 
Between August 2011 and April 2012, 74 potentially eligible patients were screened 
for inclusion. Forty six of these patients consented and were enrolled in the trial; 22 in 
the CHO group and 24 in the Control group. One patient from the Control group did 
not have surgery before the trial enrolment period finished, so was excluded. One 
additional patient, also in the Control group, remained in hospital for an extended 
period, almost eight weeks. He failed to reach our primary outcome of ‘readiness for 
discharge’ before he was transferred, so was not included in the outcome analysis. 
Other reasons for exclusion are shown in Figure 1. Over half (26; 59.0%) of the 
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enrolled participants were oncology patients, 18 (40.9%) were male; 37 (84.1%) had 
laparoscopic surgery and 4 (9.1%) had surgery under epidural anaesthesia. Other 
baseline data, by group, is shown in Table 1. 
 
None of the patients reported side-effects from consuming the CHO beverage but four 
did not drink the product before surgery, reasons for this are shown in Figure 1. 
Patients in the CHO group drank larger quantities of fluid overall than those in the 
control group (CHO 2393ml, SD 1165; Control group 1320ml, SD 982; p = 0.002). 
 
Outcomes 
There was no difference in the mean time to readiness for discharge with patients in 
the  control group on average spending 4.3 days and the CHO group spending 4.1 
days until this outcome was met (t=0.224, p=0.824). Nor were differences 
demonstrated until passage of first flatus; the control group average was 49.8 hours 
compared to 34.7 hours in the CHO group (t=1.551, p=0.129). Although the time to 
first bowel movement, on average was shorter in the CHO group (46.5 hours) 
compared with the control group (68.4 hours), the result was not statistically different 
(t=1.784, p=0.082). Table 2 shows the unadjusted results and Table 3 shows results 
adjusted for length of surgery and time from last fluid intake. 
 
Adverse outcomes 
Overall, 4 (18%) patients in the control group had an adverse event compared with 2 
(9%) in the CHO group, the difference was not statistically significant (Fisher’s exact, 
p=0.376). None of these events were related to the intervention and occurred at 
various times in the post surgical period. In the control group there was one wound 
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dehiscence in a patient admitted for repair of an enterocutaneous fistula; one episode 
was reported of an airway obstruction, which occurred in the Post Anaesthetic Care 
Unit (PACU) following an open anterior resection in a patient with sleep apnoea; one 
patient was retuned to theatre for division of adhesions and formation of an ileostomy 
eight days after an ileo-anal anastomosis; and one patient with multiple comorbidities, 
who had a hemi-colectomy, died two days after the surgery. In the intervention group, 
a patient who had an anterior resection and ileostomy was retuned to theatre for 
insertion of a urinary stent; and one morbidly obese patient with an anterior resection 
was admitted post operatively to the Intensive Care Unit, following an upper airway 
obstruction in the PACU. 
Discussion 
This is the fourth study to investigate the effect of preoperative loading with an oral, 
carbohydrate-rich nutritional supplement on length of stay in elective colorectal 
patients.   The intervention had no effect on our primary outcome, time to readiness 
for discharge. Time to first flatus and to first bowel movement were shorter, though 
not statistically so, in the intervention group. Theoretically, such a reduction could be 
due to a shorter time between ingestion of carbohydrates and surgery. It is well 
understood that starvation changes the body’s metabolism, including increased insulin 
resistance and reduced muscle function
2
. However, although those in the intervention 
group ingested a higher volume of fluid than those in the control group, they did not 
have a longer starvation period.  
 
This raises important issues about our preoperative policy, which allows patients to 
eat until midnight and to have no fluid after 05.00hrs. Delays to surgery frequently 
occur and, in our case, the average time between the last fluid intake and surgery was 
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approximately eight hours. This delay is well outside recommendations from decades 
of research and recent guidelines, which state that drinking clear fluids up to 2-hours 
before elective surgery is safe and beneficial
14, 15
.  
 
Strengths and weaknesses of the study 
The robust design, use of a ‘usual care’ group that allowed a realistic comparison 
between the intervention and control and the ability to follow-up all but two 
participants, were important features of the study. Although over one-third of 
potentially eligible patients were excluded before randomisation, for only two of these 
was the reason because the potential participant refused consent, making future, larger 
trials feasible.  
 
Recruiting participants some weeks before the date of surgery introduces the potential 
for post-randomisation loss, due to surgical cancellations or patients receiving 
treatment elsewhere. Nevertheless, only one patient was lost in this way, even though 
in some cases there was up to two months between recruitment and surgery. In 
addition, having ‘readiness to discharge’ as the primary end point may also be a 
limiting factor if patients are very ill. In our case however, only one patient failed to 
meet one or more components of the end point before being discharged, almost eight 
weeks after surgery.   
 
One important limitation to the study was the sample size. We based our sample size 
on a mean reduction of 2.5 days in time to readiness for discharge. At the time of 
planning, this reduction was drawn from results of the only available study
10
. The 
actual difference in time to readiness for discharge in our study was less than one day; 
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consequently our study was seriously underpowered to show a difference in the 
primary outcome. As a result we are unable to draw conclusions about the 
effectiveness or not of the intervention. In addition, because we were constrained by 
hospital policy, the intervention was unable to be administered as recommended. than 
recommended. So, essentially, the study compared clear fluids with high carbohydrate 
fluids. The delay between last ingestion of fluid and surgery may also have impacted 
on the study outcomes. 
Despite these limitations, there are now four trials assessing the effectiveness of CHO 
on hospital length of stay. These trials provide an opportunity for a systematic review 
and meta-analysis to enable a clearer picture to be formed about whether CHO 
confers any benefit to patient undergoing colorectal surgery. Effect estimates from 
any such review would also allow investigators to calculate a more realistic sample 
size for any future trial. 
Differences between this and other studies 
In this study the effect of preoperative carbohydrate loading on readiness to discharge 
is inconclusive. Our results are at variance with results from a small trial where 35 
participants undergoing colectomy or resection were divided into three groups (pre-
operative water drink, pre-operative fasting and preoperative carbohydrate drink)
10
. 
Time to readiness for discharge in this study was statistically shorter in the 
carbohydrate group when compared with the water group but not when compared 
with the fasting group. However, our results concur with the two other trials to have 
used hospital length of stay as an outcome
11,12
. In the first of these trials, 162 patients 
undergoing colorectal surgery or liver resections were randomly allocated to either an 
oral carbohydrate drink or a placebo taken the evening before and two hours prior to 
surgery. Outcomes of the 142 patients whose results were analysed included 
Preoperative oral carbohydrate 
 14 
postoperative fatigue, total length of hospital stay and time to ‘fit for discharge’. No 
differences between groups were found for any of these outcomes
11
. In the second 
trial, one of the three interventions was oral intake of 400mls of CHO on the evening 
before and on the morning of surgery. Length of hospital stay was assessed but no 
between group differences were demonstrated
12
. Our population was very similar to 
both of these trials and our control and intervention groups well matched for all risk 
factors, as was the Mathur (2010)
 11
 and the Kaska (2010) trials
12
. It was unclear if 
this was the case in the Noblett (2005) trial, which found a benefit for preoperative 
carbohydrate loading
10
.  
The effectiveness of enhanced preoperative nutrition has also been recently evaluated 
in a Cochrane Review. Although the review demonstrated shorter length of stay 
among those receiving enhanced nutrition, the authors included studies evaluating any 
nutritional intervention, delivered by any route (parenteral, enteral or oral)  for 
extended periods prior to surgery. Consequently, results from the review are not 
comparable with those from the current study
16
. Similarly, trials were available where 
high carbohydrate drinks were administered as a component of a fast-track protocol
17
. 
However, because the individual effect of CHO could not be estimated, comparisons 
with our results were not possible.  
As with other studies in similar populations, no adverse events related to the trial 
product were observed 
10-12
 and there were no anaesthetic complications. 
 
Implications for practice 
Until larger, independent trials provide evidence of benefit, use of high carbohydrate 
fluids to improve patient outcomes cannot be recommended.  
Implications for research 
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Independent, well designed, pragmatic trials are required to establish if pre-operative, 
high carbohydrate fluids provide any meaningful postoperative benefit. Any such trial 
should include an economic analysis, be suitably powered to detect clinically 
important differences and provide an assessment of patient preferences.   
Conclusion 
The safety of preoperative high carbohydrate fluids is confirmed but we are unable to 
confirm or refute the benefit of CHO for shorter hospital stay.  
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 Potentially eligible 
Colorectal patients undergoing elective bowel surgery and who were > 
18 years of age 
(n = 74) 
Reasons for exclusion (n = 28) 
 
 Unable to drink large quantities (n = 5) 
 Diabetic (n = 7) 
 Taking cortisone (n =  6) 
 Enrolled in another trial (n = 2) 
 Missed (n = 5) 
 Refused consent (n = 2) 
 Other (n = 1) 
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Randomized  
(n = 46) 
Allocated to CHO group 
(n = 22) 
 
Allocated to the control 
group  
(n = 24) 
 
Number included in 
outcome analysis  
N = 22 
 
 
Number included in 
outcome analysis  
N = 22 
 
Number of protocol violations = 4 
 Nausea = 2 
 Asleep = 1 
 Surgery date changed, no high 
carbohydrate drink available for 
second date = 1 
 
 
Number of protocol violations = 0 
 
 All patients in the Control group 
received standard care 
 
Post randomization exclusion (n = 0) Post randomization exclusion (n = 2) 
 Surgery cancelled (n = 1) 
 Extended hospital stay (n = 1) 
Figure 1. Flow of participants through the trial 
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Table 1.  Characteristics of study population. Values are numbers (percent) of 
patients or mean [standard deviation]. 
 CHO group  Control group 
age in years 54.5 [36.0, 79.0] 61.0 [27.0, 77.0]  
Male 8/22 (36.4) 10/22 (36.4) 
 weight  in kilos 69.3 [47.8, 142.6] 76.1[48.0, 97.7] 
ASA Grade > 2 5/22 (22.7) 3/22 (13.6) 
Oncology patient 12/22 (54.5) 14/22 (63.6) 
Epidural anaesthesia 2/22 (9.1) 2/22 (9.1) 
Time between last fluid intake and 
surgery (in hours) 
5.1 [3.1, 26.9] 6.8 [3.4, 16.7] 
Duration of surgery (in hours) 3.1 [0.4, 7.2]  3.2[0.9, 8.0] 
Laparoscopic surgery 19/22 (86.4) 18/22 (81.8) 
Type of surgery   
      Anterior resection 11/22 (50.0) 7/22 (31.8) 
      Hemicolectomy 3/22 (13.6) 2/22 (9.1) 
      Restoration of continuity 5/22 (22.7) 8/22 (36.4) 
      Sigmoid colectomy 1/22 (4.5) 0/22 (0.0) 
      Total colectomy 1/22 (4.5) 1/22 (4.5) 
      Proctectomy and pouch 1/22 (4.5) 3/22 (13.6)  
      Other surgery 6/22 (27.2) 9/22 (40.9) 
 
N.B. Total sum of types of surgery is greater than 22 in each group; some patients had 
more than one type of surgery. 
Preoperative oral carbohydrate 
 21 
Table 2: Unadjusted outcome variables* 
 Group mean 95% CI t p-
value lower upper 
Time to readiness  
for discharge (days) 
 
Control 
group 
 (n = 21)
 a
 
4.3 3.2 5.7 0.224 0.824 
CHO group 
(n = 22) 
4.1 3.2 5.4 
Time to fist  
flatus (hours) 
 
Control 
group 
(n = 22)  
49.8 33.4 74.2 1.551 0.129 
CHO group 
(n = 22)  
34.7 26.0 46.1 
Time  to first  
bowel movement 
(hours) 
Control 
group 
(n = 22)  
68.4 50.6 92.5 1.784 0.082 
CHO group  
(n = 21)
 b
 
46.5 33.2 65.2 
 
* Outcome variables were logarithmically transformed and geometric means and 
confidence intervals are shown 
a
 One patient died before discharge 
b
 Time of bowel movement not recorded for one patient 
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Table 3: Outcome variables adjusted by duration of surgery and time to last  
fluid * 
 
* Outcome variables were logarithmically transformed and geometric means and 
confidence intervals are shown 
a
 One patient died before discharge 
b
 Time of bowel movement not recorded for one patient 
 
 
 Group mean 95% CI F p-value 
lower upper 
Time to readiness  
for discharge (days) 
 
Control group 
(n = 21)
a
   
4.4 3.3 5.7 0.106 0.746 
CHO group 
(n = 22)   
4.1 3.2 5.3 
Time to fist  
flatus (hours) 
 
Control group 
(n = 22)   
50.1 35.5 70.5 2.468 0.124 
CHO group 
(n = 22)   
34.5 24.7 48.2 
Time  to first  
bowel movement (hours) 
Control group 
(n = 22)   
68.8 50.6 93.6 3.349 0.075 
CHO group 
(n = 21)
 b
   
46.2 33.7 63.4 
